Evidence map›Paper›PMID 33757480›Full record

ReviewBMC public health2021

An initiative of cooperation in Zika virus research: the experience of the ZIKABRA study in Brazil.

Silvana Pereira Giozza, Ximena Pamela Díaz Bermúdez, Edna Oliveira Kara, Guilherme Amaral Calvet, Ana Maria Bispo de Filippis, Marcus Vinícius Guimarães Lacerda, Camila Helena Aguiar Bôtto-Menezes, Marcia da Costa Castilho, Rafael Freitas Oliveira Franca, Armando Menezes Neto and 7 more

Open access · goldAbstract readReview
In one paragraph

Review in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 3 countries.

Silvana Pereira GiozzaDepartment of Chronic Condition Diseases and Sexually Transmitted Infections, Health Surveillance Secretariat, Ministry of Health, Brazil, SRTVN Quadra 701, Lote D, Edifício PO700 - 5° andar, Brasília, Distrito Federal, 70719-040, Brazil. silvana.giozza@aids.gov.br.ORCID 0000-0002-5435-4678
Ximena Pamela Díaz BermúdezPublic Health Department, University of Brasilia, Brasilia, Brazil.
Edna Oliveira KaraWorld Health Organization, Geneva, Switzerland.
Guilherme Amaral CalvetEvandro Chagas National Institute of Infectious Diseases, Rio de Janeiro, Brazil.
Ana Maria Bispo de FilippisOswaldo Cruz Institute, Rio de Janeiro, Brazil.
Marcus Vinícius Guimarães LacerdaInstituto Leônidas & Maria Deane, Fiocruz, Manaus, Brazil.
Camila Helena Aguiar Bôtto-MenezesAmazonas State University, Manaus, Brazil.
Marcia da Costa CastilhoTropical Medicine Foundation Dr Heitor Vieira Dourado, Manaus, Brazil.
Rafael Freitas Oliveira FrancaOswaldo Cruz Foundation - Institute Aggeu Magalhães, Recife, Brazil.
Armando Menezes NetoOswaldo Cruz Foundation - Institute Aggeu Magalhães, Recife, Brazil.
Casey StormeHenry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.
Noemia S LimaHenry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.
Kayvon ModjarradEmerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
Maria Cristina Pimenta de OliveiraDepartment of Chronic Condition Diseases and Sexually Transmitted Infections, Health Surveillance Secretariat, Ministry of Health, Brazil, SRTVN Quadra 701, Lote D, Edifício PO700 - 5° andar, Brasília, Distrito Federal, 70719-040, Brazil.
Gerson Fernando Mendes PereiraDepartment of Chronic Condition Diseases and Sexually Transmitted Infections, Health Surveillance Secretariat, Ministry of Health, Brazil, SRTVN Quadra 701, Lote D, Edifício PO700 - 5° andar, Brasília, Distrito Federal, 70719-040, Brazil.
Nathalie BroutetWorld Health Organization, Geneva, Switzerland.
ZIKABRA Study Team
Fundação de Medicina Tropical · BRHenry M. Jackson Foundation · USMinistério da Saúde · BRWorld Health Organization · CHFundação Oswaldo Cruz · BRUniversidade de Brasília · BRInstituto Evandro Chagas · BR

Funding

Study on the persistence of Zika virus (ZIKV) in body fluids of patients with ZIKV infection in BrazilR21AI139777 · NIAID · FUNDACAO OSWALDO CRUZ · PI CALVET, GUILHERME AMARAL · 2018 to 2019
$272k
Brazilian Ministry of Health Convênio 837059/2016, Processo 25000162039201616Henry M. Jackson Foundation for the Advancement of Military Medicine W81XWH-18-2-0040NIAID NIH HHS R21 AI139777Wellcome TrustWellcome Trust 206522/Z/17/ZWorld Health Organization 001World Health Organization TSA1–2017/720873–0World Health Organization TSA2–2017/731359–0
6 · The paper itself

Abstract

backgroundThe Zika virus outbreak has triggered a set of local and global actions for a rapid, effective, and timely public health response. A World Health Organization (WHO) initiative, supported by the Department of Chronic Condition Diseases and Sexually Transmitted Infections (DCCI) of the Health Surveillance Secretariat (SVS), Brazil Ministry of Health (MoH) and other public health funders, resulted in the start of the "Study on the persistence of Zika virus in body fluids of patients with ZIKV infection in Brazil - ZIKABRA study". The ZIKABRA study was designed to increase understanding of how long ZIKV persists in bodily fluids and informing best measures to prevent its transmission. Data collection began in July 2017 and the last follow up visit occurred in 06/26/2020.

methodsA framework for the ZIKABRA Cooperation initiative is provided through a description and analysis of the mechanisms, strategies and the ethos that have guided the models of international governance and technical cooperation in health for scientific exchange in the context of a public health emergency. Among the methodological strategies, we included a review of the legal documents that supported the ZIKABRA Cooperation; weekly documents produced in the meetings and working sessions; technical reports; memorandum of understanding and the research protocol.

conclusionWe highlight the importance of working in cooperation between different institutional actors to achieve more significant results than that obtained by each group working in isolation. In addition, we point out the advantages of training activities, ongoing supervision, the construction of local installed research capacity, training academic and non-academic human resources, improvement of laboratory equipment, knowledge transfer and the availability of the ZIKABRA study protocol for development of similar studies, favoring the collective construction of knowledge to provide public health emergency responses. Strategy harmonization; human resources and health services; timing and recruiting particularities and processing institutional clearance in the different sites can be mentioned as challenges in this type of initiative.

Indexed as

Zika VirusZika Virus InfectionBrazilDisease OutbreaksHumansPublic HealthInternational cooperation in healthOutbreakPublic health emergencyZika virus

Identifiers

PMID33757480
PMCPMC7985753
OpenAlexW3138352724

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.